Chinese General Practice ›› 2018, Vol. 21 ›› Issue (26): 3160-3163.DOI: 10.12114/j.issn.1007-9572.2018.00.111
• Monographic Research • Previous Articles Next Articles
Published:
2018-09-15
Online:
2018-09-15
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2018.00.111
[1]ZHOU M G,WANG H D,ZHU J,et al.Cause-specific mortality for 240 causes in China during 1990—2013:a systematic subnational analysis for the Global Burden of Disease Study 2013[J].Lancet,2016,387(10015):251-272.DOI:10.1016/S0140-6736(15)00551-6.3162 [2]中华医学会老年医学分会,《中华内科杂志》编辑委员会,《中华老年医学杂志》编辑委员会.阿司匹林在动脉粥样硬化性心血管疾病中的临床应用:中国专家共识(2016)[J].中华内科杂志,2017,56(1):68-80.DOI:10.3760/cma.j.issn.0578-1426.2017.01.20.3162 Geriatrics Branch of Chinese Medical Association,Editorial Board of Chinese Journal of Internal Medicine,Editorial Board of Chinese Journal of Geriatrics.Aspirin use in patients with atherosclerotic cardiovascular disease:the 2016 Chinese expert consensus statement[J].Chinese Journal of Internal Medicine,2017,56(1):68-80.DOI:10.3760/cma.j.issn.0578-1426.2017.01.20.3162 [3]Antithrombotic Trialists'(ATT) Collaboration,BAIGENT C,BLACKWELL L,et al.Aspirin in the primary and secondary prevention of vascular disease:collaborative meta-analysis of individual participant data from randomized trials[J].Lancet,2009,373(9678):1849-1860.DOI:10.1016/S0140-6736(09)60503-1.3162 [4]VAN KRUIJSDIJK R C,VISSEREN F L,RIDKER P M,et al. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer,cardiovascular disease and gastrointestinal bleeding in healthy women[J].Heart,2015,101(5):369-376.DOI:10.1136/heartjnl-2014-306342.3162 [5]GUIRGUIS-BLAKE J M,EVANS C V,SENGER C A,et al.Aspirin for the primary prevention of cardiovascular events:a systematic evidence review for the U.S.Preventive Services Task Force[J].Ann Intern Med,2016,164(12):804-813.DOI:10.7326/M15-2113.3162 [6]GUIRGUIS-BLAKE J M,EVANS C V,SENGER C A,et al.Aspirin for the primary prevention of cardiovascular events:a systematic evidence review for the U.S.Preventive Services Task Force[M].Rockville:Agency for Healthcare Research and Quality,2015.3162 [7]LI L,GERAGHTY O C,MEHTA Z,et al.Age-specific risks,severity,time course,and outcome of bleeding on long-term antiplatelet treatment after vascular events:a population-based cohort study[J].Lancet,2017,390(10093):490-499.DOI:10.1016/S0140-6736(17)30770-5.3163 [8]BERGER J S,RONCAGLIONI M C,AVANZINI F,et al.Aspirin for the primary prevention of cardiovascular events in women and men:a sex-specific meta-analysis of randomized controlled trials[J].JAMA,2006,295(3):306-313.DOI:10.1001/jama.295.3.306.3163 [9]MESCHIA J F,BUSHNELL C,BODEN-ALBALA B,et al.Guidelines for the primary prevention of stroke:a statement for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2014,45(12):3754-3832.DOI:10.1161/STR.0000000000000046.3163 [10]CAMPBELL C L,SMYTH S,MONTALESCOT G,et al.Aspirin dose for the prevention of cardiovascular disease[J].JAMA,2007,297(18):2018-2024.DOI:10.1001/jama.297.18.2018.3163 [11]IKEDA Y,SHIMADA K,TERAMOTO T,et al.Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors:a randomized clinical trial[J].JAMA,2014,312(23):2510-2520.DOI:10.1001/jama.2014.15690.3163 [12]OGAWA H,NAKAYAMA M,MORIMOTO T,et al.Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes:a randomized controlled trial[J].JAMA,2008,300(18):2134-2141.DOI:10.1001/jama.2008.623.3163 [13]SAITO Y,OKADA S,OGAWA H,et al.Low-dose aspirin for primary prevention of cardiovascular events in patients with type 2 diabetes mellitus 10-year follow-up of a randomized controlled trial[J].Circulation,2017,135(7):659-670.DOI:10.1161/CIRCULATIONAHA.116.025760.3163 [14]SUNDSTR?M J,HEDBERG J,THURESSON M,et al.Low-dose aspirin discontinuation and risk of cardiovascular events:a Swedish nationwide,population-based cohort study[J].Circulation,2017,136(13):1183-1192.DOI:10.1161/CIRCULATIONAHA.117.028321.3163 [15]FOX C S,GOLDEN S H,ANDERSON C,et al.Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence:a scientific statement from the American Heart Association and the American Diabetes Association[J].Circulation,2015,132(8):691-718.DOI:10.1161/CIR.0000000000000230.3163 [16]BIBBINS-DOMINGO K,U.S.Preventive Services Task Force.Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer:U.S.Preventive Services Task Force Recommendation Statement[J].Ann Intern Med,2016,164(12):836-845.DOI:10.7326/M16-0577.3163 [17]PIEPOLI M F,HOES A W,AGEWALL S,et al.2016 European guidelines on cardiovascular disease prevention in clinical practice:the Sixth Joint Task Force of the Europe Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice(constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation(EACPR)[J].Eur Heart J,2016,37(29):2315-2381.DOI:10.1093/eurheartj/ehw106.3163 [18]U.S.Food and Drug Administration.Use of aspirin for primary prevention of heart attack and stroke[EB/OL].(2014-02-05)[2016-06-05].http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm390574.htm.3163 [19]中国医师协会心血管内科医师分会,中国医师协会心血管内科医师分会血栓防治专业委员会,中华医学会消化内镜学分会,等.急性冠状动脉综合征抗栓治疗合并出血防治多学科专家共识[J].中华内科杂志,2016,55(10):813-824.DOI:10.3760/cma.j.issn.0578-1426.2016.10.021.3163 Chinese College of Cardiovascular Physicians,Chinese College of Cardiovascular Physicians Working Group on Thrombosis,Chinese Society of Digestive Endoscopy,et al.Multidisciplinary expert consensus on the prevention and management of bleeding in patients with acute coronary syndrome receiving antithrombotic agents[J].Chinese Journal of Internal Medicine,2016,55(10):813-824.DOI:10.3760/cma.j.issn.0578-1426.2016.10.021.3163 [20]抗血小板药物消化道损伤的预防和治疗中国专家共识组.抗血小板药物消化道损伤的预防和治疗中国专家共识(2012更新版)[J].中华内科杂志,2013,52(3):264-270.DOI:10.3760/cma.j.issn.0578-1426.2013.03.027.3163 Chinese Expert Recommendation on Prevention and Treatment of Gastrointestinal Injury Related to Antiplatelet Therapy Group.Consensus of Chinese experts on prevention and treatment of gastrointestinal injury caused by antiplatelet drugs (2012 update)[J].Chinese Journal of Internal Medicine,2013,52(3):264-270.DOI:10.3760/cma.j.issn.0578-1426.2013.03.027.3163 [21]冯雪茹,刘梅林,刘芳,等.阿司匹林剂量对高龄老年患者血小板功能的影响[J].北京大学学报(医学版),2016,48(5):835-840.DOI:10.3969/j.issn.1671-167X.2016.05.016.3163 FENG X R,LIU M L,LIU F,et al.Dose-response of aspirin on platelet function in very elderly patients[J].Journal of Peking University(Health Sciences),2016,48(5):835-840.DOI:10.3969/j.issn.1671-167X.2016.05.016.3163 [22]陈夏欢,刘梅林,秦名芳,等.小剂量阿司匹林对老年人血小板聚集率的影响和短期安全性评估一项多中心随机对照临床研究[J].中国循环杂志,2018,33(5):457-462.DOI:10.3969/j.issn.1000-3614.2018.05.009.3163 CHEN X H,LIU M L,QIN M F,et al.Anti-aggregation effect and short-term safety evaluation of low-dose aspirin therapy in the elderly Chinese population:a multicenter randomized controlled clinical trial[J].Chinese Circulation Journal,2018,33(5):457-462.DOI:10.3969/j.issn.1000-3614.2018.05.009.3163 |
[1] | YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172. |
[2] | PAN Yaojia, WANG Weiqiang, YI Weizhuo, GAO Bing, FU Fanglin, HAN Zheng, SUN Meng, DONG Yaqin, GU Huaicong. Relationship between Triglyceride-glucose Index and Risk of Cardiovascular Diseases in Middle-aged Obese Residents of Different Genders [J]. Chinese General Practice, 2023, 26(29): 3628-3635. |
[3] | CHEN Runlin, HE Tufeng, TAO Lijun, QIN Lingqiao, ZHANG Dacheng, ZHANG Yifan, ZHAO Min, ZHONG Qiuan. Effects of Cardiovascular Risk Factors on the Progression of Carotid Intima-media Thickening [J]. Chinese General Practice, 2023, 26(14): 1709-1715. |
[4] | LIU Taotao, LI Tianrong, WANG Xue, CHEN Jiameng, SHUAI Zhiqin, LI Lisheng, XU Shangfu. Nanoparticle- and Exosome-based Targeted Drug Delivery Systems Used in the Diagnosis and Treatment of Atherosclerosis: Opportunities and Challenges [J]. Chinese General Practice, 2023, 26(08): 903-910. |
[5] | ZHANG Haicheng, YU Xinyan, WANG Hongyu, XUE Tao, LIAO Xiaoyang, FAN Yongmei, ZHANG Qinghong. Discussion on the Difficulties and Bottlenecks in the Management of Remote ECG-based Screening for Cardiovascular Disease Risk in Hierarchical Diagnosis and Treatment [J]. Chinese General Practice, 2023, 26(05): 525-531. |
[6] | WU Changyong, BAO Suli, XU Fei, PENG Yunzhu. Latest Advances in Exercise-induced Autophagy in Improving Cardiovascular Disease Prognosis [J]. Chinese General Practice, 2023, 26(05): 629-634. |
[7] | WANG Zhe, ZHAO Haibin, WANG Guoliang, MA Xiaojuan, YIN Huijun. Complete Revascularization for Acute Myocardial Infarction and Multivessel Disease: an Overview of Systematic Reviews [J]. Chinese General Practice, 2023, 26(02): 142-153. |
[8] | TANG Zhaoyun, HE Yang, CHEN Cong, YANG Xiaodan, WU Xinhua, LIU Hong. Risk Assessment of Ischemic Cardiovascular Disease in Rural Naxi Population in Low-to-high Altitudes [J]. Chinese General Practice, 2022, 25(36): 4522-4527. |
[9] | SUN Zhenzhen, LIU Huanhuan, CHEN Kaining, LOU Qingqing. New Advances in the Value of the Normal Urinary Albumin as a Predictor of Multiple Diseases [J]. Chinese General Practice, 2022, 25(33): 4191-4195. |
[10] | LIAO Jia, WEI Shuangyi, LIU Gang. Overview and Trends of Premature Deaths Due to Four Major Noncommunicable Diseases among Shenzhen Permanent Residents, 2014-2020 [J]. Chinese General Practice, 2022, 25(32): 4085-4090. |
[11] | Fang HE, Fulan WANG, Liling XIE, Shuya LING, Mingchao XIAO. Application of TeamSTEPPS in the Management of Out-of-hospital Medication Safety for Patients with Chronic Heart Failure [J]. Chinese General Practice, 2022, 25(30): 3768-3774. |
[12] | Xu CHEN, Hanxiong LIU, Xiuqiong YU, Lianchao CHENG, Lingyao QI, Siqi YANG, Yan LUO, Lin CAI. Total Occlusion of the Culprit Artery in Non-ST-segment Elevation Acute Coronary Syndrome: an Analysis of the Influencing Factors and Long-term Outcome Following Percutaneous Coronary Intervention [J]. Chinese General Practice, 2022, 25(27): 3365-3372. |
[13] | Ziao RUI, Dongpu DAI, Yingying GUO, Shuo PANG, Yuanhang ZHOU, Yang DU, Xiaoyan ZHAO, Jianzeng DONG. Efficacy and Related Inflencing Factors of Intra-aortic Balloon Counterpulsation Combined with Extracorporeal Membrane Oxygenation in Patients with Acute Myocardial Infarction and Cardiogenic Shock [J]. Chinese General Practice, 2022, 25(21): 2597-2604. |
[14] | Liang MA, Hailin YAN, Xue XIAO, Jinlin YANG. Effects of Season and Temperature on Gastrointestinal Bleeding in Patients with Ischemic Heart Disease [J]. Chinese General Practice, 2022, 25(21): 2589-2596. |
[15] | Siqi YANG, Hanxiong LIU, Xiuqiong YU, Lin TONG, Jin LI, Lianchao CHENG, Xu CHEN, Lingyao QI, Yan LUO, Lin CAI. Sex-specific Analysis of the Management and Outcome of Elderly Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2022, 25(14): 1694-1699,1706. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||